Top 50 Companies in Transcriptomics Technologies Market: Spherical Insights Analysis (2024–2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Transcriptomics Technologies Market Size is projected to Grow from USD 7.23 Billion in 2024 to USD 13.6 Billion by 2035, at a CAGR of 5.91% during the forecast period 2025–2035. Population growth and the need for different chemical raw materials in different industries are driving up demand for the transcriptomics technologies market.
Introduction
Transcriptomics technology can be used to study an organism's transcriptome, or all of its RNA transcripts. Scientists can examine the intricate transcriptome landscapes in many biological contexts by employing transcriptomics techniques. These techniques significantly increase our understanding of biological processes by exposing patterns of gene expression, regulatory mechanisms, and molecular pathways. They also support the creation of new medications, therapeutic targets, and biomarkers for a variety of diseases. Transcriptomics is a promising field that could advance our understanding of life and health as it continues to evolve with new instruments and applications. By making it possible to conduct a thorough investigation of gene expression at the individual cell level, single-cell transcriptomics has completely transformed the worldwide transcriptomics industry. As scientists actively look for methods to understand cellular heterogeneity in a variety of diseases, including cancer and neurological disorders, this topic is quickly gaining interest. Because single-cell transcriptomics is crucial for comprehending tumor complexity and creating individualized treatments, the rising incidence of cancer feeds this trend and supports the expansion of the transcriptomics market.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Transcriptomics Technologies Market.
Transcriptomics Technologies Market Size & Statistics
- The Market Size for Transcriptomics Technologies Was Estimated to be worth USD 7.23 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 5.91% between 2025 and 2035.
- The Global Transcriptomics Technologies Market Size is anticipated to reach USD 13.6 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Transcriptomics Technologies Market
- Asia Pacific is Expected to Grow the fastest during the forecast period in the Transcriptomics Technologies Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the transcriptomics technologies market. The development of biotech infrastructure, growing investment in genomic medicine, and the prevalence of chronic diseases will all contribute to the Asia-Pacific region's notable growth. For instance, China, Japan, South Korea, and India are making large investments in AI-based bioinformatics systems, CRISPR-based transcriptomics, and RNA sequencing. The expanding number of biotech start-ups in India and the Chinese government's emphasis on precision medicine are also driving industry expansion.
North America is expected to generate the highest demand during the forecast period in the transcriptomics technologies market. The market for transcriptomics technology is dominated in North America because of the presence of leading biotech and pharmaceutical businesses, the high adoption of next-generation sequencing (NGS), and the substantial government financing for genomic research. The United States is at the forefront of single-cell transcriptomics, RNA-sequencing (RNA-Seq) research, and drug development applications due to the efforts of the FDA, NIH, and commercial research organizations. The market is also growing as a result of more biotech companies partnering with academic institutions.
Top 5 trends in the Transcriptomics Technologies Market
- Integration of AI and machine learning for data analysis
- Advancements in single-cell transcriptomics
- Widespread adoption of high-throughput and next-generation sequencing (NGS)
- Expansion of transcriptomics applications in personalized and precision medicine
- Increased demand for biomarker identification and RNA-based therapeutics
- Growth in spatial transcriptomics for tissue-level molecular profiling
- Automation and high-throughput platforms streamlining workflows
- Investment surges from pharmaceutical and biotech sectors
- Collaborations between academia and industry for innovation
- Rapid expansion in Asia-Pacific markets due to government initiatives
1. Integration of AI and machine learning for data analysis
AI and machine learning are revolutionizing transcriptomics by enabling efficient, large-scale analysis of gene expression data. These technologies accelerate data interpretation, identify novel patterns, and unlock deeper biological insights, significantly supporting advancements in drug discovery and biomarker identification.
2. Advancements in single-cell transcriptomics
Single-cell transcriptomics allows researchers to analyze gene expression at the resolution of individual cells, providing unprecedented detail on cellular diversity within tissues. This trend is vital in cancer research, developmental biology, and neurological disorders, enabling precise disease modeling and the development of targeted therapies.
3. Widespread adoption of high-throughput and next-generation sequencing (NGS)
Next-generation sequencing technologies have become the backbone of transcriptomic studies, offering massive data output, reduced costs, and high accuracy. NGS platforms are now standard in research and clinical labs, driving innovations in genomics, diagnostics, and therapeutic development.
4. Expansion of transcriptomics applications in personalized and precision medicine
Transcriptomics is central to the shift toward personalized medicine, as its insights into gene expression help tailor treatments to individual patients. The technology is increasingly applied to identify disease-specific biomarkers and support RNA-based therapeutic strategies for oncology and rare diseases.
5. Increased demand for biomarker identification and RNA-based therapeutics
The search for reliable biomarkers for early disease detection and targeted treatments is fueling transcriptomics adoption. Simultaneously, RNA-based drugs—supported by transcriptome analysis—are gaining traction in the pharmaceutical industry, spurred by high-profile successes and growing investment
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the transcriptomics technologies market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Transcriptomics Technologies Market
- 10x Genomics
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- Qiagen
- Fluidigm Corporation
- NanoString Technologies
- PerkinElmer
- Takara Bio
- Roche Sequencing Solutions
- BGI Genomics
- GE Healthcare
- Promega Corporation
- Partek Incorporated
- LC Sciences
- Hamilton Company
- Genewiz
- Tecan Group
- Strand Life Sciences
- Eurofins Genomics
- Analytik Jena
- Zymo Research
1. 10x Genomics — Headquarters: Pleasanton, California, USA
10x Genomics is a trailblazer in transcriptomics technologies, specializing in single-cell and spatial transcriptomics platforms that provide unparalleled insight into cellular diversity and gene expression. The company’s flagship Chromium and Visium systems empower researchers worldwide to perform high-resolution transcriptome profiling critical for oncology, immunology, and neuroscience studies. Renowned for its pioneering innovations, 10x Genomics bridges the gap between raw data and biological interpretation, accelerating discoveries in precision medicine and RNA-based research. Constantly advancing its technologies and analytical software, 10x Genomics remains a pivotal contributor to the rapid growth and adoption of transcriptomics across academic and pharmaceutical sectors, cementing its position as a leader synonymous with cutting-edge cellular analysis.
2. Illumina — Headquarters: San Diego, California, USA
Illumina is a dominant force in next-generation sequencing (NGS) and transcriptomics technologies, renowned for delivering high-throughput, cost-effective sequencing solutions. Its extensive product portfolio, including the NovaSeq series, supports large-scale RNA sequencing essential for genomics research, diagnostics, and therapeutic development. Illumina’s platforms enable comprehensive transcriptome analysis, fostering biomarker discovery and integration with multi-omics approaches. The company’s commitment to innovation and quality drives advancements in personalized medicine, helping decode complex diseases through RNA analysis. Illumina is a household name in transcriptomics, continually expanding its technological capabilities and supporting a broad global customer base in research and clinical applications.
3. Thermo Fisher Scientific — Headquarters: Waltham, Massachusetts, USA
Thermo Fisher Scientific stands as a major player in transcriptomics, providing a broad range of RNA analysis tools that include qPCR, microarrays, and RNA sequencing. The company supports both bulk and single-cell transcriptomics workflows with automated, cloud-enabled platforms that enhance scalability and data accuracy. Thermo Fisher’s products serve diverse markets, spanning biopharmaceutical R&D, diagnostics, and academia. Its widespread adoption is reflected in its commitment to biomarker discovery and RNA-based therapeutics development. Known for reliability and innovation, Thermo Fisher Scientific continuously invests in new technologies and acquisitions to maintain a stronghold in global transcriptomics markets and accelerate breakthroughs in molecular biology.
4. Agilent Technologies — Headquarters: Santa Clara, California, USA
Agilent Technologies specializes in high-quality microarray and gene expression platforms for transcriptomics research. Its comprehensive kits and instruments facilitate sensitive and reproducible RNA quantification, enabling high-throughput gene expression studies essential for biomarker discovery and precision medicine. Agilent’s technology integration includes artificial intelligence to streamline data analysis and accelerate insight generation. The company collaborates extensively with pharmaceutical and clinical researchers, strengthening its presence in the transcriptomics market. The name Agilent Technologies is synonymous with robust analytical solutions that adapt to evolving scientific challenges, making it a reliable partner for researchers pursuing innovation in transcriptome profiling and RNA-based therapeutic applications.
5. Bio-Rad Laboratories — Headquarters: Hercules, California, USA
Bio-Rad Laboratories is a key contributor to transcriptomics technologies, offering advanced real-time PCR, droplet digital PCR, and RNA quantification platforms. These flexible tools support gene expression studies integral to biomarker discovery, drug development, and clinical diagnostics. Bio-Rad focuses on ease of use and reliability, making transcriptomics accessible to a wide range of researchers in academia and industry. Its global distribution network and customer support reinforce its position as a trusted provider of molecular biology solutions. The company’s ongoing commitment to product innovation and upgrades ensures its critical role in expanding the capabilities and applications of transcriptomic research worldwide.
Are you ready to discover more about the transcriptomics technologies market?
The report provides an in-depth analysis of the leading companies operating in the global transcriptomics technologies market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- 10x Genomics
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- Qiagen
- Fluidigm Corporation
- Others.
Conclusion
The transcriptomics technologies market is experiencing rapid growth, driven by innovations in single-cell analysis, spatial transcriptomics, and next-generation sequencing. Leading companies such as 10x Genomics, Illumina, Thermo Fisher Scientific, Agilent Technologies, and Bio-Rad Laboratories are shaping the industry through cutting-edge platforms and integrated bioinformatics solutions. Increasing demand for biomarker discovery, precision medicine, and RNA-based therapeutics continues to expand market opportunities. Collaborations between academia, biotech, and pharmaceutical sectors are accelerating advancements and the commercialization of these technologies. Overall, transcriptomics is emerging as a cornerstone of modern life sciences, enabling deeper biological insights and transformative healthcare solutions.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?